Company intelligence / Profile preview
Koye Pharmaceuticals
- Ownership
- Private
- Employees
- ~700
- Development stage
- Commercial
Overview
Koye Pharmaceuticals operates as a specialty pharmaceutical company focused on the Indian market. It has a broad commercial portfolio across respiratory diseases, gynaecology/IVF, cardiovascular/metabolic disorders, and general wellness. The company has recently partnered with Sonde Health to co-develop vocal biomarker technology for early detection and monitoring of COPD using voice analysis—a first-of-kind pharma collaboration in India. Its marketed products include generics such as Spirodin (doxofylline) and Spirodin-Ax.
- Therapeutic areas
- PulmonologyCardiovascularEndocrinologyOtherWomen's Health
- Modalities
- Small molecules (primarily)nutraceuticalsalso involved in digital health/biomarker technology via partnership
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Koye Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Koye Pharmaceuticals.